SR one

Applying Insight Creating Value.

Investment Fund Manager | United Kingdom of Great Britain and Northern Irela | Access to Information

 

• http://www.srone.com/Default.aspx

Overview

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care.We have a team of investment professionals located in the US and UK. As a Team our experience spans basic science industry and the market. We take an active role in our portfolio companies and work with management teams and our fellow venture investors to create significant value.Our current portfolio includes approximately 35 private and public companies and since our founding in 1985 we have invested over $830MM in the biotech space.Our expanded remit also focuses on maximizing the value of GSK technological innovation to establish new businesses and revenue opportunities across a range of industries.

Investor Type	Legal Structure	Operating Status	Members
Investment Fund Manager	Partnership	Operating

Portfolio

Investors / Funders

Team

Funds

Impact

Social Objectives:

Environmental Objectives:

Operational Impact:

Impact Reports & Metrics

Offices